Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
All Cosmos Bio-Tech HoldingTPE:4148 +0.16%85 Cyclically Adjusted PS Ratio is 0.71 as of Sep. 09, 2026, which is 30% below its 10-year median of 1.01. GuruFocus rates TPE:4148 with a GF Score™ of 85/100 and a GF Value™ of NT$49.80 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 199 Agriculture companies, All Cosmos Bio-Tech Holding ranks better than 62.81% on this metric.
The historical rank and industry rank for All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio or its related term are showing as below:
TPE:4148'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.68 Med: 1.01 Max: 1.24
Current: 0.73
During the past years, All Cosmos Bio-Tech Holding's highest Cyclically Adjusted PS Ratio was 1.24. The lowest was 0.68. And the median was 1.01.
TPE:4148's Cyclically Adjusted PS Ratio is ranked better than 62.81% of 199
companies
in the Agriculture industry
Industry Median: 1.02
vs TPE:4148: 0.73
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
All Cosmos Bio-Tech Holding's adjusted revenue per share data for the three months ended in Jun. 2026 was NT$14.644. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is NT$43.85 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
All Cosmos Bio-Tech Holding (TPE:4148) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
All Cosmos Bio-Tech Holding Cyclically Adjusted PS Ratio Related Terms
All Cosmos Bio-Tech Holding Cyclically Adjusted PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
All Cosmos Bio-Tech Holding Cyclically Adjusted PS Ratio Chart
TPE:4148 vs CTVA, CF, MOS: Cyclically Adjusted PS Ratio Comparison
For the Agricultural Inputs subindustry, All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
All Cosmos Bio-Tech Holding Cyclically Adjusted PS Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio falls into.
All Cosmos Bio-Tech Holding Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 0.71 mean?
All Cosmos Bio-Tech Holding (TPE:4148) has a Cyclically Adjusted PS Ratio of 0.71 as of Sep. 09, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on All Cosmos Bio-Tech Holding and its competitors. This is 30% below median its historical median of 1.01. Over the past decade, All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio has ranged from 0.68 to 1.24. According to the industry distribution chart, All Cosmos Bio-Tech Holding ranks #74 out of 199 companies in the Agriculture industry, placing it in the top 37.2%.
Is All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio too high?
All Cosmos Bio-Tech Holding's current Cyclically Adjusted PS Ratio of 0.71 is 30% below median its 10-year median of 1.01. Over the past 10 years, this metric has ranged from a low of 0.68 to a high of 1.24. The Agriculture industry median Cyclically Adjusted PS Ratio is 1.02. All Cosmos Bio-Tech Holding's value of 0.71 is 30.4% below this industry median. Based on the distribution chart, All Cosmos Bio-Tech Holding ranks #74 out of 199 companies in the Agriculture industry, which is above the industry midpoint. Overall, All Cosmos Bio-Tech Holding has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does All Cosmos Bio-Tech Holding's Cyclically Adjusted PS Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, All Cosmos Bio-Tech Holding ranks #74 out of 199 companies for Cyclically Adjusted PS Ratio. This puts All Cosmos Bio-Tech Holding in the upper half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.02. All Cosmos Bio-Tech Holding's value of 0.71 is 30.4% below this benchmark. Historically, All Cosmos Bio-Tech Holding's own Cyclically Adjusted PS Ratio has ranged from 0.68 to 1.24 over the past decade. While the company's 10-year median is 1.01 vs. the industry median of 1.02, All Cosmos Bio-Tech Holding has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for an Agriculture company?
The median Cyclically Adjusted PS Ratio among Agriculture companies is 1.02, based on 199 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. All Cosmos Bio-Tech Holding's current Cyclically Adjusted PS Ratio of 0.71 is 30.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on All Cosmos Bio-Tech Holding and its competitors. For the Agriculture industry, the median Cyclically Adjusted PS Ratio is 1.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. All Cosmos Bio-Tech Holding's current Cyclically Adjusted PS Ratio is 0.71, which is 30% below median its own 10-year median of 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is All Cosmos Bio-Tech Holding stock overvalued right now?
Based on GuruFocus' analysis, All Cosmos Bio-Tech Holding (TPE:4148) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$49.80, compared to a current price of NT$31.15 — trading 37.4% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.71, which is 30% below median its 10-year median of 1.01 and 30.4% below the Agriculture industry median of 1.02. All Cosmos Bio-Tech Holding's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For All Cosmos Bio-Tech Holding (TPE:4148), the current Cyclically Adjusted PS Ratio is 0.71 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is All Cosmos Bio-Tech Holding (TPE:4148) Overvalued in 2026?
Based on GuruFocus' analysis, All Cosmos Bio-Tech Holding stock appears to be undervalued.
The current stock price of NT$31.15 is trading 37.4% below its estimated GF Value™ of NT$49.80.
GuruFocus considers All Cosmos Bio-Tech Holding to be Significantly Undervalued.
Key valuation signals for TPE:4148:
Cyclically Adjusted PS Ratio: 0.71 (30% below median its 10-year median of 1.01)
GF Value™: NT$49.80 vs. price of NT$31.15 (37.4% below fair value)
Industry Position: 30.4% below the Agriculture median (#74 of 199)
No single metric tells the full story. See the TPE:4148 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
All Cosmos Bio-Tech Holding Corp is involved in a wide range of industries, mainly divided into 4 focused areas, including agriculture, waste reutilization, health care and pharmaceutical, and research and development of microbials. The group's reportable segments are All Cosmos Industries Sdn. Bhd. (ACI), Sabah Softwoods Hybrid Fertiliser Sdn. Bhd. (SSHF) and others. The majority of its revenue is generated from the ACI segment, which operates as a manufacturer and marketer of Bio-Organic and Bio-Chemical fertilizers. It offers various organic, bio-chemical, bio-control, and chemical fertilizers. Geographically, the group derives maximum revenue from Malaysia and the rest from other markets.
85GF Score
Get the complete analysis for TPE:4148
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4148 has been successfully added to your 
